Skip to Main content
Number of documents


Guillemot Johann

Journal articles14 documents

  • Johann Guillemot, Marlène Guérin, Anne-Francoise Cailleux, Antoine-Guy Lopez, Jean Marc Kuhn, et al.. Characterization of the EM66 Biomarker in the Pituitary and Plasma of Healthy Subjects With Different Gonadotroph Status and Patients With Gonadotroph Tumor. Frontiers in Endocrinology, Frontiers, 2019, ⟨10.3389/fendo.2019.00102⟩. ⟨hal-02045905⟩
  • Marine Guillaud-Bataille, Bruno Ragazzon, Aurélien de Reyniès, Claire Chevalier, Isabelle Francillard, et al.. IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma.. PLoS ONE, Public Library of Science, 2014, 9 (8), pp.e103744. ⟨10.1371/journal.pone.0103744⟩. ⟨inserm-01068039⟩
  • Johann Guillemot, Marlène Guérin, Erwan Thouennon, Maite Montero-Hadjadje, Jérôme Leprince, et al.. Characterization and Plasma Measurement of the WE-14 Peptide in Patients with Pheochromocytoma. PLoS ONE, Public Library of Science, 2014, 9 (2), pp.88698 - 88698. ⟨10.1371/journal.pone.0088698⟩. ⟨hal-01706411⟩
  • Marlène Guérin, Johann Guillemot, Erwan Thouennon, Alice Pierre, Fatima-Zohra El-Yamani, et al.. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma. Regulatory Peptides, Elsevier, 2010, 165 (1), pp.21 - 29. ⟨10.1016/j.regpep.2010.06.003⟩. ⟨hal-01706413⟩
  • Erwan Thouënnon, Alice Pierre, Yannick Tanguy, Johann Guillemot, Destiny-Love Manecka, et al.. Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival. Endocrine-Related Cancer, BioScientifica, 2010, 17 (3), pp.637 - 651. ⟨10.1677/ERC-10-0109⟩. ⟨hal-01706426⟩
  • Christophe Breton, Marie-Amélie Lukaszewski, Pierre-Yves Risold, Mihaela Enache, Johann Guillemot, et al.. Maternal prenatal undernutrition alters the response of POMC neurons to energy status variation in adult male rat offspring.. AJP - Endocrinology and Metabolism, American Physiological Society, 2009, 296 (3), pp.E462-72. ⟨10.1152/ajpendo.90740.2008⟩. ⟨hal-00483720⟩
  • Johann Guillemot, Patricia Compagnon, Dorthe Cartier, Erwan Thouennon, Christian Bastard, et al.. Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors. Endocrine-Related Cancer, BioScientifica, 2008, 16 (1), pp.281 - 290. ⟨10.1677/ERC-08-0190⟩. ⟨hal-01706408⟩
  • Mohammed Boutahricht, Johann Guillemot, Maïté Montero-Hadjadje, Youssef Barakat, Seloua Ouezzani, et al.. Immunohistochemical distribution of the secretogranin II-derived peptide EM66 in the rat hypothalamus: A comparative study with jerboa. Neuroscience Letters, Elsevier, 2007, 414 (3), pp.268-272. ⟨10.1016/j.neulet.2006.12.033⟩. ⟨hal-02344634⟩
  • Erwan Thouennon, Abdel Elkahloun, Johann Guillemot, Anne-Paule Gimenez-Roqueplo, Jérôme Bertherat, et al.. Identification of Potential Gene Markers and Insights into the Pathophysiology of Pheochromocytoma Malignancy. Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2007, 92 (12), pp.4865 - 4872. ⟨10.1210/jc.2007-1253⟩. ⟨hal-01706427⟩
  • Johann Guillemot, Djida Aït-Ali, Valérie Turquier, Maite Montero-Hadjadje, Alain Fournier, et al.. Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells. Regulatory Peptides, Elsevier, 2006, 137 (1-2), pp.79 - 88. ⟨10.1016/j.regpep.2006.04.023⟩. ⟨hal-01706412⟩
  • Johann Guillemot, Youssef Anouar, Maïté Montero-Hadjadje, Eric Grouzmann, Luca Grumolato, et al.. Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma. International Journal of Cancer, Wiley, 2006, 118 (8), pp.2003 - 2012. ⟨10.1002/ijc.21571⟩. ⟨hal-01706431⟩
  • Johann Guillemot, Laure Barbier, Erwan Thouennon, Virginie Vallet-Erdtmann, Maite Montero-Hadjadje, et al.. Expression and processing of the neuroendocrine protein secretogranin II in benign and malignant pheochromocytomas.. Annals of the New York Academy of Sciences, Wiley, 2006, 1073, pp.527-32. ⟨10.1196/annals.1353.056⟩. ⟨hal-00653225⟩
  • Laurent Yon, Johann Guillemot, Maite Montero-Hadjadje, Luca Grumolato, Jérôme Leprince, et al.. Identification of the Secretogranin II-Derived Peptide EM66 in Pheochromocytomas as a Potential Marker for Discriminating Benign Versus Malignant Tumors. Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2003, 88 (6), pp.2579-2585. ⟨10.1210/jc.2002-021748⟩. ⟨hal-01706414⟩
  • Maite Montero-Hadjadje, Georges Pelletier, Laurent Yon, Songyun Li, Johann Guillemot, et al.. Biochemical Characterization and Immunocytochemical Localization of EM66, a Novel Peptide Derived from Secretogranin II, in the Rat Pituitary and Adrenal Glands. Journal of Histochemistry and Cytochemistry, Histochemical Society, 2003, 51 (8), pp.1083 - 1095. ⟨10.1177/002215540305100812⟩. ⟨hal-01706425⟩